JP4272259B2 - 診断用イメージングのための脂肪酸アナログの立体異性体 - Google Patents

診断用イメージングのための脂肪酸アナログの立体異性体 Download PDF

Info

Publication number
JP4272259B2
JP4272259B2 JP52066997A JP52066997A JP4272259B2 JP 4272259 B2 JP4272259 B2 JP 4272259B2 JP 52066997 A JP52066997 A JP 52066997A JP 52066997 A JP52066997 A JP 52066997A JP 4272259 B2 JP4272259 B2 JP 4272259B2
Authority
JP
Japan
Prior art keywords
group
fatty acid
stereoisomer
imaging
radionuclide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP52066997A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000502059A (ja
JP2000502059A5 (enExample
Inventor
デビット アール． エルマレー
Original Assignee
モレキュラ インサイト ファーマシューティカルズ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by モレキュラ インサイト ファーマシューティカルズ インコーポレイテッド filed Critical モレキュラ インサイト ファーマシューティカルズ インコーポレイテッド
Publication of JP2000502059A publication Critical patent/JP2000502059A/ja
Publication of JP2000502059A5 publication Critical patent/JP2000502059A5/ja
Application granted granted Critical
Publication of JP4272259B2 publication Critical patent/JP4272259B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Nuclear Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP52066997A 1995-12-01 1996-11-25 診断用イメージングのための脂肪酸アナログの立体異性体 Expired - Fee Related JP4272259B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US786395P 1995-12-01 1995-12-01
US60/007,863 1995-12-01
PCT/US1996/019024 WO1997019705A1 (en) 1995-12-01 1996-11-25 Stereoisomers of fatty acid analogs for diagnostic imaging

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008006447A Division JP4937144B2 (ja) 1995-12-01 2008-01-16 診断用イメージングのための脂肪酸アナログの立体異性体

Publications (3)

Publication Number Publication Date
JP2000502059A JP2000502059A (ja) 2000-02-22
JP2000502059A5 JP2000502059A5 (enExample) 2004-10-21
JP4272259B2 true JP4272259B2 (ja) 2009-06-03

Family

ID=21728502

Family Applications (3)

Application Number Title Priority Date Filing Date
JP52066997A Expired - Fee Related JP4272259B2 (ja) 1995-12-01 1996-11-25 診断用イメージングのための脂肪酸アナログの立体異性体
JP2008006447A Expired - Fee Related JP4937144B2 (ja) 1995-12-01 2008-01-16 診断用イメージングのための脂肪酸アナログの立体異性体
JP2011232673A Withdrawn JP2012036215A (ja) 1995-12-01 2011-10-24 診断用イメージングのための脂肪酸アナログの立体異性体

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2008006447A Expired - Fee Related JP4937144B2 (ja) 1995-12-01 2008-01-16 診断用イメージングのための脂肪酸アナログの立体異性体
JP2011232673A Withdrawn JP2012036215A (ja) 1995-12-01 2011-10-24 診断用イメージングのための脂肪酸アナログの立体異性体

Country Status (8)

Country Link
US (4) US7005119B2 (enExample)
EP (2) EP0869821B1 (enExample)
JP (3) JP4272259B2 (enExample)
AT (2) ATE353019T1 (enExample)
CA (1) CA2238860C (enExample)
DE (1) DE69636881T2 (enExample)
ES (2) ES2374743T3 (enExample)
WO (1) WO1997019705A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE353019T1 (de) * 1995-12-01 2007-02-15 Molecular Insight Pharm Inc Stereoisomere von fettsäureanalogen zur diagnostischen bildgebung
US20090117032A1 (en) * 1998-09-08 2009-05-07 The General Hospital Corporation Imaging Agents for Early Detection and Monitoring of Cardiovascular Plaque
EP0992245A1 (en) * 1998-09-16 2000-04-12 Goldham Bioglan Pharma GmbH Radio-contrast agents
EP1040825A1 (en) * 1999-03-11 2000-10-04 K.U. Leuven Research & Development Means for diagnosing bladder carcinoma
DE60030270T2 (de) * 1999-04-14 2007-08-30 Molecular Insight Pharmaceuticals, Inc., Cambridge Fettsaure analoge zur diagnose von kranzarterie erkrankungen
WO2003084575A1 (en) * 2002-04-01 2003-10-16 Biostream, Inc. Pendant fatty acid imaging agents
AU2004232297B2 (en) * 2003-04-17 2010-11-04 The General Hospital Corporation Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid
JP2012526129A (ja) * 2009-05-04 2012-10-25 ワシントン・ユニバーシティ 脂肪酸代謝および貯蔵を画像化するためのｐｅｔ放射性追跡子
DE102010010666A1 (de) * 2010-03-01 2011-09-01 Sven Reske Diagnose und Therapie von Krebserkrankungen mittels Fettsäuren

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6802651A (enExample) * 1968-02-23 1969-08-26
DE2828623C2 (de) * 1978-06-29 1983-11-17 Kernforschungsanlage Jülich GmbH, 5170 Jülich Mit radioaktivem Flour markierte C↓1↓↓6↓-bis C↓1↓↓8↓- Fettsäuren, ein Verfahren zu ihrer Herstellung sowie deren Verwendung
DE2947500C2 (de) * 1979-11-24 1984-05-10 Dutschka, Klaus, 4300 Essen Radiojodierte ω -Phenylfettsäuren, ihre Herstellung und deren Verwendung zur szintigraphischen Untersuchung des Herzmuskels und der Leber
FR2508902B1 (fr) * 1981-07-02 1985-09-06 Commissariat Energie Atomique Procede de preparation extemporanee d'un acide gras injectable, marque a l'iode radioactif et preparation de derives iodes utilisables pour la mise en oeuvre de ce procede
US4524059A (en) * 1983-01-28 1985-06-18 The General Hospital Corporation Fatty acid analogs
US4942231A (en) * 1984-05-24 1990-07-17 Mallinckrodt, Inc. Method of preparing a chlorinated, brominated, radio-brominated, iodinated and/or radioiodinated aromatic or heteroaromatic compound
CA1243329A (en) * 1985-03-11 1988-10-18 Amersham Int Plc TECHNETIUM COMPLEXES WITH PROPYLENE-AMINE-OXIMES
US4746505A (en) * 1985-04-26 1988-05-24 President And Fellows Of Harvard College Technetium radiodiagnostic fatty acids derived from bisamide bisthiol ligands
US4764358A (en) * 1985-04-30 1988-08-16 The United States Of America As Represented By The United States Department Of Energy Radiolabeled dimethyl branched long chain fatty acid for heart imaging
US4877599A (en) 1986-11-10 1989-10-31 New England Deaconess Hospital Corporation Detection of vascular disease with labelled antibodies
ATE89271T1 (de) * 1987-11-19 1993-05-15 Univ Vanderbilt Radiojodhaltige benzamide und verfahren zu ihrer verwendung als radiobildende agenzien.
US5242681A (en) * 1990-03-12 1993-09-07 Research Corporation Technologies, Inc. Lipophilic contrast agents for diagnostic image analysis
US7238340B1 (en) * 1991-11-27 2007-07-03 Cis Bio International Monoamine, diamide, thiol-containing metal chelating agents
ATE353019T1 (de) * 1995-12-01 2007-02-15 Molecular Insight Pharm Inc Stereoisomere von fettsäureanalogen zur diagnostischen bildgebung
EP2324857A1 (en) * 1997-09-08 2011-05-25 The General Hospital Corporation Imaging agents for early detection of cardiovascular plaque
US7060251B1 (en) * 1997-09-08 2006-06-13 The General Hospital Corporation Imaging agents for early detection and monitoring of cardiovascular plaque
DE60030270T2 (de) * 1999-04-14 2007-08-30 Molecular Insight Pharmaceuticals, Inc., Cambridge Fettsaure analoge zur diagnose von kranzarterie erkrankungen
EP1265865A2 (en) * 2000-03-21 2002-12-18 The Procter & Gamble Company Difluorobutyric acid derivatives and their use as metalloprotease inhibitors
AU2004232297B2 (en) * 2003-04-17 2010-11-04 The General Hospital Corporation Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid

Also Published As

Publication number Publication date
ES2374743T3 (es) 2012-02-21
US7314609B2 (en) 2008-01-01
CA2238860C (en) 2009-01-13
US20080247948A1 (en) 2008-10-09
ATE353019T1 (de) 2007-02-15
US7005119B2 (en) 2006-02-28
HK1102262A1 (en) 2007-11-09
CA2238860A1 (en) 1997-06-05
JP4937144B2 (ja) 2012-05-23
JP2012036215A (ja) 2012-02-23
EP1767224B1 (en) 2011-10-05
HK1016494A1 (en) 1999-11-05
EP0869821A4 (en) 2002-08-28
JP2000502059A (ja) 2000-02-22
ATE526995T1 (de) 2011-10-15
EP0869821A1 (en) 1998-10-14
EP1767224A2 (en) 2007-03-28
JP2008201774A (ja) 2008-09-04
US20030215386A1 (en) 2003-11-20
EP0869821B1 (en) 2007-01-31
DE69636881D1 (de) 2007-03-22
US20070128110A1 (en) 2007-06-07
WO1997019705A1 (en) 1997-06-05
EP1767224A3 (en) 2007-11-28
ES2281906T3 (es) 2007-10-01
DE69636881T2 (de) 2007-09-20
US20060078495A1 (en) 2006-04-13

Similar Documents

Publication Publication Date Title
JP4937144B2 (ja) 診断用イメージングのための脂肪酸アナログの立体異性体
US7534418B2 (en) Imaging agents
Hjelstuen Technetium-99m chelators in nuclear medicine. A review
Roivainen et al. Gallium-labelled peptides for imaging of inflammation
Kabasakal Technetium-99m ethylene dicysteine: a new renal tubular function agent
JPH03505094A (ja) 動脈映像のための合成ペプチド
JP2007291134A (ja) 心臓血管および血栓の造影剤、方法、およびキット
Tamaki et al. Radionuclide assessment of myocardial fatty acid metabolism by PET and SPECT
Gould Quantitative imaging in nuclear cardiology.
Wen et al. Immuno-SPECT/PET imaging with radioiodinated anti-PD-L1 antibody to evaluate PD-L1 expression in immune-competent murine models and PDX model of lung adenocarcinoma
CN105524610B (zh) 多模态白细胞分子探针化合物、制备方法及应用
Lu et al. Design, synthesis, and biological evaluation of a 99m Tc-labeled small-molecule tracer for PD-L1 imaging
Wolfram et al. Assessment of peripheral arterial vascular disease with radionuclide techniques
Yang et al. Impact of boronate capping groups on biological characteristics of novel 99mTc (III) complexes [99mTcCl (CDO)(CDOH) 2B-R](CDOH2= cyclohexanedione dioxime)
HK1016494B (en) Stereoisomers of fatty acid analogs for diagnostic imaging
Adam A general comparison of functional imaging in nuclear medicine with other modalities
HK1102262B (en) Stereoisomers of fatty acid analogs for diagnostic imaging
US20030152511A1 (en) Radiolabled vasoactive intestinal peptide analogs for imaging and therapy
Wagner Jr 2003 SNM highlights lecture from proof of principle to proof of value
Van der Wall et al. Nuclear cardiology and cardiac magnetic resonance
Knuuti et al. Highlights of the annual congress of the European Association of Nuclear Medicine, Copenhagen 2007
Fischman et al. Imaging techniques in pharmacology
Faulds et al. Imciromab Pentetate (Monoclonal Antimyosin Antibody Fab) A Review of its Pharmacology and Clinical Potential in the Diagnosis of Cardiac Disorders
Fischman et al. In vivo imaging in drug discovery and design
Strauss Nuclear medicine at the crossroads

Legal Events

Date Code Title Description
A72 Notification of change in name of applicant

Free format text: JAPANESE INTERMEDIATE CODE: A721

Effective date: 20050817

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070116

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20070330

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20070521

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070711

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070918

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080116

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080220

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20080220

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20080410

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080924

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20081218

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081224

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20081225

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20090204

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20090227

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120306

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120306

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130306

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130306

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140306

Year of fee payment: 5

LAPS Cancellation because of no payment of annual fees